Becker | Jotup

AXIS Appoints W. Marston Becker as Chair-Elect of Board of Directors

Retrieved on:

torsdag, februari 29, 2024

Fintech, Professional Services, Insurance, Finance, AXS, AXIS, AXIS Capital, Becker, Chair, Management

AXIS Capital Holdings Limited ("AXIS Capital") (NYSE: AXS) today announced that W. Marston (Marty) Becker will succeed Henry B. Smith as non-executive Chair of its Board of Directors.

Key Points:

AXIS Capital Holdings Limited ("AXIS Capital") (NYSE: AXS) today announced that W. Marston (Marty) Becker will succeed Henry B. Smith as non-executive Chair of its Board of Directors.
The transition will take place in May of 2024, timed to the Company’s Annual General Meeting.
“There is no better individual to succeed me as Chair of the AXIS Board of Directors than Marty Becker.
His guidance as Chair will be integral as AXIS takes further steps forward in realizing its ambition to achieve specialty leadership.”
Mr. Becker, who joined the AXIS Board of Directors in June of 2020, has led a distinguished career in the (re)insurance industry spanning four decades.

Redeux Energy Launches Corporate Equity Raise; Retains Marathon Capital as Financial Advisor

Retrieved on:

torsdag, mars 7, 2024

DENVER, March 7, 2024 /PRNewswire/ -- Redeux Energy Partners LLC ("Redeux"), a leading utility-scale solar and energy storage development company, has retained Marathon Capital, LLC ("Marathon Capital") as its exclusive financial advisor to raise corporate-level equity capital.

Key Points:

DENVER, March 7, 2024 /PRNewswire/ -- Redeux Energy Partners LLC ("Redeux"), a leading utility-scale solar and energy storage development company, has retained Marathon Capital, LLC ("Marathon Capital") as its exclusive financial advisor to raise corporate-level equity capital.
The process is targeting investors interested in taking a minority position in the cap table, closing by Q3 2024.
Proceeds will be deployed to expand pipeline origination efforts, fund ongoing development for existing pipeline, and continuously improve the platform's capabilities.
Shaw Renewable Investments, Community Energy, BayWa r.e., Canadian Solar, and BP Solar to lead Redeux's origination strategy and project portfolio development.

On Feb 6th, Penn Medicine Becker ENT & Allergy Opens a New Location to Increase Access to Quality Care in Woodbury, NJ

Retrieved on:

onsdag, februari 28, 2024

WOODBURY, N.J., Feb. 28, 2024 /PRNewswire-PRWeb/ -- Expanding Patient Care: Penn Medicine Becker ENT & Allergy's New Woodbury Facility

Key Points:

WOODBURY, N.J., Feb. 28, 2024 /PRNewswire-PRWeb/ -- Expanding Patient Care: Penn Medicine Becker ENT & Allergy's New Woodbury Facility
The new Penn Medicine Becker ENT & Allergy location in Woodbury is part of their ongoing mission to deliver comprehensive care for ear, nose, throat, and allergy issues to more patients.
What the New Penn Medicine Becker ENT & Allergy Location Means for Woodbury, NJ
The opening of the new Becker ENT location in Woodbury is a major boon for the local community.
Penn Medicine Becker ENT & Allergy offers a vast array of ENT and allergy services .
Contacting Penn Medicine Becker ENT & Allergy for Care in Woodbury, NJ
To experience the quality and personalized care that Penn Medicine Becker ENT & Allergy offers, residents of Woodbury, NJ, and surrounding areas can schedule an appointment.

Newport Healthcare Celebrates Eating Disorders Awareness Week With Reminder That Early Intervention Can Save Lives

Retrieved on:

tisdag, februari 27, 2024

NEDA, Betty Ford Center, EDAW, Eating, Hope, Eating disorder, Food, Counselor, Nursing, Marriage, Becker, Trauma, Opioid, Mortality, Dietary supplement

NASHVILLE, Tenn., Feb. 27, 2024 /PRNewswire/ -- Newport Healthcare , a nationwide network of evidence-based treatment programs for primary mental health disorders and co-occurring substance use and eating disorders, is celebrating Eating Disorders Awareness Week (EDAW) by reminding the public that early intervention and treatment can greatly improve the chance of successful recovery.

Key Points:

NASHVILLE, Tenn., Feb. 27, 2024 /PRNewswire/ -- Newport Healthcare , a nationwide network of evidence-based treatment programs for primary mental health disorders and co-occurring substance use and eating disorders, is celebrating Eating Disorders Awareness Week (EDAW) by reminding the public that early intervention and treatment can greatly improve the chance of successful recovery.
Eating Disorders Awareness Week takes place February 26 through March 3, 2024.
"Newport Healthcare is uniquely positioned to support clients with mental health challenges and eating disorders or disordered eating," said Kara Becker, licensed marriage and family therapist, certified eating disorders specialist, and National Director of Eating Disorder Programs for Newport Healthcare.
Newport Healthcare is an Eating Disorders Awareness Week Collaborator with the National Eating Disorder Association (NEDA) which reports that almost a quarter of children and adolescents worldwide (22%) show disordered eating or eating behaviors and distorted attitudes towards food, weight, shape, and appearance.

Fear Free®, LLC Unveils a Revitalized Brand at WVC 2024

Retrieved on:

måndag, februari 19, 2024

Marketing, Pig, Cattle, Animal, Growth, Work, Food, Conference, Chicken, History, LAS, Becker, Heart, WVC

LAS VEGAS, Feb. 19, 2024 /PRNewswire-PRWeb/ -- Fear Free®, the single most transformative initiative in the history of companion animal practice, today unveiled its dynamic new brand at the 96th WVC Annual Veterinary Conference. The new brand, which embodies the company's commitment to improving the emotional and physical wellbeing of all animals, will be showcased at Fear Free's booth at WVC.

Key Points:

Fear Free® Unveils New Branding at 96th WVC Annual Veterinary Conference, Emphasizing Enhanced Animal Wellbeing and Expanded Services.
LAS VEGAS, Feb. 19, 2024 /PRNewswire-PRWeb/ -- Fear Free®, the single most transformative initiative in the history of companion animal practice, today unveiled its dynamic new brand at the 96th WVC Annual Veterinary Conference.
The new brand, which embodies the company's commitment to improving the emotional and physical wellbeing of all animals, will be showcased at Fear Free's booth at WVC.
Andru Valpy, Marketing Manager for Fear Free, expressed excitement about the new brand's debut: "Revealing our new brand is a milestone moment.

Sportsman’s Warehouse Holdings, Inc. Appoints Steven R. Becker to its Board of Directors

Retrieved on:

fredag, januari 26, 2024

Middlebury College, University, Edmentum, Environment, Becker, Warehouse, Management

WEST JORDAN, Utah, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Sportsman’s Warehouse Holdings, Inc. (“Sportsman’s Warehouse” or the “Company”) (Nasdaq: SPWH) announced today that Steven R. Becker has been appointed as an independent member of its Board of Directors (the “Board”), effective immediately.

Key Points:

WEST JORDAN, Utah, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Sportsman’s Warehouse Holdings, Inc. (“Sportsman’s Warehouse” or the “Company”) (Nasdaq: SPWH) announced today that Steven R. Becker has been appointed as an independent member of its Board of Directors (the “Board”), effective immediately.
“We are pleased to welcome Steve to Sportsman’s Warehouse and believe he will bring valuable perspectives from his years of specialty retail and investment management experience,” said Rich McBee, Chairman of the Board.
Mr. Becker previously spent 20 years in the investment management industry with a focus on investing in middle market public companies.
Mr. Becker received a Bachelor of Arts degree from Middlebury College and a Juris Doctor from the University of Florida.

Bowen Acquisition Corp Announces Entering into Merger Agreement with Shenzhen Qianzhi BioTech Company

Retrieved on:

fredag, januari 19, 2024

NewCo, Health, Temperature, Chlorine, Mergers and acquisitions, Ozone, Acquisition, Becker, Holding company

New York, NY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bowen Acquisition Corp (NASDAQ: BOWN) (“BOWN”), a special purpose acquisition company, announced the execution of an agreement and plan of merger (the “Merger Agreement”) with Shenzhen Qianzhi BioTechnology Co., Ltd (“Qianzhi BioTech”), a biotech company engaged in development, manufacturing and sales of ozonated health and wellness products in China.

Key Points:

New York, NY, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bowen Acquisition Corp (NASDAQ: BOWN) (“BOWN”), a special purpose acquisition company, announced the execution of an agreement and plan of merger (the “Merger Agreement”) with Shenzhen Qianzhi BioTechnology Co., Ltd (“Qianzhi BioTech”), a biotech company engaged in development, manufacturing and sales of ozonated health and wellness products in China.
Pursuant to the Merger Agreement, BOWN’s wholly owned subsidiary, Bowen Merger Sub, a Cayman Islands exempted company, will merge (the “Merger” or the “Business Combination”) with and into Qianzhi Group Holding (Cayman) Limited, parent of Qianzhi BioTech and an exempted company incorporated with limited liability in the Cayman Islands (“NewCo”), with NewCo being the surviving company of the Merger and becoming a wholly-owned subsidiary of BOWN.
Qianzhi BioTech, based in Shenzhen, China, is a health and wellness focused biotech company and an early adopter and developer of plant-based and ozonated products for antibacterial, skincare, gynecological and andrological applications.
Becker & Poliakoff is serving as U.S. legal advisor to Qianzhi BioTech, and Jingsh & H Y Leung (Qianhai) Law Firm is serving as PRC legal advisor to Qianzhi BioTech.

ZOLL Foundation Marks Ten Years of Providing “Seed” Grants to Young Medical Researchers Around the World

Retrieved on:

tisdag, januari 23, 2024

To date, the ZOLL Foundation has awarded more than $6 million in grants to 150 individuals and their respective institutions in 20 countries on six continents.

Key Points:

To date, the ZOLL Foundation has awarded more than $6 million in grants to 150 individuals and their respective institutions in 20 countries on six continents.
Now in its tenth year, the ZOLL Foundation expects its total awards to exceed $7 million in 2024.
“The ZOLL Foundation’s vision is that our seed grants will support follow-on research that improves care and enhances training in clinical practice,” said Ward Hamilton, President of the ZOLL Foundation Board of Directors.
Early support by the ZOLL Foundation was incredibly valuable for me as an investigator.

CureDuchenne Announces Educational Events for Families and Caregivers of Individuals with Duchenne or Becker Muscular Dystrophy

Retrieved on:

tisdag, januari 23, 2024

Hope, House, Research, Health, Open House, Knowledge, Muscular dystrophy, Lunch, Becker muscular dystrophy, Conference, Disease, Caregiver, Breakfast, Becker, Duchenne muscular dystrophy, Education

NEWPORT BEACH, Calif., Jan. 23, 2024 /PRNewswire/ -- CureDuchenne, a global leader in research, patient care and innovation for improving and extending the lives of those living with Duchenne muscular dystrophy, has announced its schedule of CureDuchenne Cares workshops and dinner sessions for the first half of the year, as well as its annual conference. CureDuchenne Cares provides interactive outreach programs to educate, empower, support and improve connections among families and caregivers of individuals with Duchenne muscular dystrophy, one of the most common and severe forms of muscular dystrophy, or Becker muscular dystrophy.

Key Points:

CureDuchenne Cares provides interactive outreach programs to educate, empower, support and improve connections among families and caregivers of individuals with Duchenne muscular dystrophy, one of the most common and severe forms of muscular dystrophy, or Becker muscular dystrophy.
"At CureDuchenne, we are committed to accelerating a cure for Duchenne muscular dystrophy and fostering a community where families and caregivers can find strength, support and hope," said Debra Miller, founder and CEO of CureDuchenne.
"Our CureDuchenne Cares events are designed to be more than just educational; they are a lifeline, connecting individuals to a network of care, understanding, and the latest advancements in treatment.
We believe in empowering our community with knowledge and resources, ensuring that no one faces the challenges of Duchenne or Becker alone."

Gaza war: how South Africa's genocide case against Israel is shaping up

Retrieved on:

onsdag, januari 17, 2024

With the death toll approaching 24,000 in the Palestinian territory, South Africa’s lawyers laid out the grounds on which they are accusing Israel of breaching the 1948 Genocide Convention, while Israel’s legal team have presented their counter- arguments.

Key Points:

With the death toll approaching 24,000 in the Palestinian territory, South Africa’s lawyers laid out the grounds on which they are accusing Israel of breaching the 1948 Genocide Convention, while Israel’s legal team have presented their counter- arguments.
Israel in turn has denied this, arguing that it has been exercising its fundamental right to self-defence under international law.
Read more:
South Africa has made its genocide case against Israel in court.
Here's what both sides said and what happens next
The UN’s genocide convention was adopted by the General Assembly on December 9 1948.

Genocide in Gaza?

They backed this assertion by quoting some of the more incendiary statements by the far-right members of the Israeli government.
On November 2023, Israel’s heritage minister, Amichai Eliyahu, claimed that there was no such thing as non-combatants in Gaza and that dropping a nuclear weapon there was an “option”.
But South Africa’s application reported other controversial statements from those senior leaders as well.

Israel’s defence

They maintained that the Israel Defense Forces campaign in Gaza was justified by the inalienable right of self-defence.
Because of this, it was within the stringent parameters of international humanitarian law.
Hamad said: “We must teach Israel a lesson, and we will do it twice and three times.

What the case means

Palestinians have traditionally sought legitimacy and recognition by trying to embed their national aspirations and rights in the lexicon of international law.
But that reversal alone might retain enough symbolic clout to infer a decisive blow to Israel’s international status.

Carlo Aldrovandi does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.